ATOPIX THERAPEUTICS

atopix-therapeutics-logo

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel class of oral anti-allergic medicines, called CRTH2 antagonists, to treat atopic dermatitis, asthma and allergic rhinitis. Its lead candidate is currently being studied in a Phase 2 clinical trial for moderate to severe atopic dermatitis in several leading European dermatology centres.

#People #Financial #Website #More

ATOPIX THERAPEUTICS

Industry:
Biotechnology Life Science Medical

Founded:
2012-01-01

Address:
Abingdon, Oxfordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.atopixtherapeutics.co.uk

Total Employee:
1+

Status:
Closed

Contact:
(440) 123-5841

Email Addresses:
[email protected]

Total Funding:
10.46 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx DigiCert SSL CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Thawte SSL



Current Advisors List

john-bell_image

John Bell Non-Executive Director @ Atopix Therapeutics
Board_member

regina-hodits_image

Regina Hodits Board of Directors, Member @ Atopix Therapeutics
Board_member
2010-01-01

Current Employees Featured

roy-pettipher_image

Roy Pettipher
Roy Pettipher Director of Research @ Atopix Therapeutics
Director of Research
2012-10-01

andrew-zambanini_image

Andrew Zambanini
Andrew Zambanini Chief Medical Officer @ Atopix Therapeutics
Chief Medical Officer
2015-09-01

not_available_image

Mick Hunter
Mick Hunter Chief Scientific Officer & Director of Development @ Atopix Therapeutics
Chief Scientific Officer & Director of Development

Investors List

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Venture Round - Atopix Therapeutics

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Debt Financing - Atopix Therapeutics

wellington-partners_image

Wellington Partners

Wellington Partners investment in Series A - Atopix Therapeutics

sr-one_image

SR One

SR One investment in Series A - Atopix Therapeutics

bessemer-venture-partners_image

Bessemer Venture Partners

Bessemer Venture Partners investment in Series A - Atopix Therapeutics

red-abbey-venture-partners_image

Red Abbey Venture Partners

Red Abbey Venture Partners investment in Series A - Atopix Therapeutics

mpm-capital_image

MPM Capital

MPM Capital investment in Series A - Atopix Therapeutics

biomedical-catalyst-fund_image

Biomedical Catalyst Fund

Biomedical Catalyst Fund investment in Grant - Atopix Therapeutics

Official Site Inspections

http://www.atopixtherapeutics.co.uk

  • Host name: 104.247.82.54
  • IP address: 104.247.82.54
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "Atopix Therapeutics" on Search Engine